Utrogestan available for HRT

Utrogestan (progesterone) is a progestogen indicated for the adjunctive use with oestrogen in postmenopausal women with an intact uterus.

The recommended dose is 200mg daily at bedtime, for 12 days, from day 15 to day 26 of each cycle. Withdrawal bleeding may occur in the following week.

Alternatively 100mg can be given at bedtime from day one to day 25 of each cycle, withdrawal bleeding being less with this treatment schedule.

Further information: Ferring 01753 214800

Go to: Utrogestan MIMS drug entry

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Trial of interferon beta in COVID-19 patients begins in UK

Trial of interferon beta in COVID-19 patients begins in UK

A global phase III clinical trial to evaluate an inhaled...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

New muscle spasm treatment option

New muscle spasm treatment option

Myopridin (pridinol) can be prescribed to treat skeletal...